相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke
Thavarak Ouk et al.
CURRENT DRUG TARGETS (2013)
Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
Jing Jin et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson's disease
Juliet M. Taylor et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-δ AGONIST PROVIDES NEUROPROTECTION IN THE 1-METHYL-4-PHENYL-1,2,3, 6-TETRAHYDROPYRIDINE MODEL OF PARKINSON'S DISEASE
H. L. Martin et al.
NEUROSCIENCE (2013)
Role of Oxidative Stress in Parkinson's Disease
Onyou Hwang
Experimental Neurobiology (2013)
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
Nicole Exner et al.
EMBO JOURNAL (2012)
Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms
Deepak Kumar Bhateja et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Protective Effects of Fenofibrate Against the Inflammatory Cytokines in Lipopolysaccharide-Induced Mice Brain Tissues
Hyun Wook Park et al.
ANNALS OF GERIATRIC MEDICINE AND RESEARCH (2012)
Ameliorative Effects of GW1929, a Nonthiazolidinedione PPARγ Agonist,on Inflammation and Apoptosis in Focal Cerebral Ischemic-Reperfusion Injury
Ravinder K. Kaundal et al.
CURRENT NEUROVASCULAR RESEARCH (2011)
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)
W. G. J. Reid et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats
Bhupesh Sharma et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Protein aggregation in Parkinson's disease
V. Gundersen
ACTA NEUROLOGICA SCANDINAVICA (2010)
Effects of the Endogenous PPAR-α Agonist, Oleoylethanolamide on MDMA-Induced Cognitive Deficits in Mice
Ainhoa Plaza-Zabala et al.
SYNAPSE (2010)
Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease
Pramod Kumar et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats
XueMing Li et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2009)
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease
Nicoletta Schintu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Apoptotic Mechanisms After Cerebral Ischemia
Brad R. S. Broughton et al.
STROKE (2009)
Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: Therapeutic implications for Parkinson's disease explained via in silico studies
Balusamy Jagatha et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug
A. Hanafy et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Therapeutic use of agonists of the nuclear receptor PPARγ in Alzheimer's disease
Gary Landreth
CURRENT ALZHEIMER RESEARCH (2007)
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease:: Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not
Alexandre Kreisler et al.
BRAIN RESEARCH (2007)
Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats
Asif R. Pathan et al.
LIFE SCIENCES (2006)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method
Irfan Rahman et al.
NATURE PROTOCOLS (2006)
Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats
S Sonkusare et al.
LIFE SCIENCES (2005)
Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: Implications for multiple sclerosis
PD Storer et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat
DG Kabra et al.
BRAIN RESEARCH BULLETIN (2004)
Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats
M Thiyagarajan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Dementia associated with Parkinson's disease
M Emre
LANCET NEUROLOGY (2003)
Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
T Breidert et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia
C Da Cunha et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Risk of dementia in Parkinson's disease - A community-based, prospective study
D Aarsland et al.
NEUROLOGY (2001)
分享论文
